Abstract
Bepridil is an effective antiarrhythmic drug on supraventricular and ventricular arrhythmias, and inhibitor of calmodulin. Recent investigations have been elucidating that bepridil exerts antiarrhythmic effects through its acute and chronic application for patients. The aim of this study was to identify the efficacy and the potential mechanism of bepridil on the inward-rectifier potassium channel in neonatal rat cardiomyocytes in acute- and long-term conditions. Bepridil inhibited inward-rectifier potassium current (I K1) as a short-term effect with IC50 of 17 μM. Bepridil also reduced I K1 of neonatal cardiomyocytes when applied for 24 h in the culture medium with IC50 of 2.7 μM. Both a calmodulin inhibitor (W-7) and an inhibitor of calmodulin-kinase II (KN93) reduced I K1 when applied for 24 h as a long-term effect in the same fashion, suggesting that the long-term application of bepridil inhibits I K1 more potently than that of the short-term application through the inhibition of calmodulin kinase II pathway in cardiomyocytes.
Similar content being viewed by others
References
Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:D668–D672
Uchino T, Lee TS, Kaku T, Yamashita N, Noguchi T, Ono K (2005) Voltage-dependent and frequency-independent inhibition of recombinant Cav3.2 T-type Ca2+ channel by bepridil. Pharmacology 74:174–181
Berger F, Borchard U, Hafner D (1989) Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibers. Naunyn Schmiedebergs Arch Pharmacol 339:638–646
Wang JC, Kiyosue T, Kiriyama K, Arita M (1999) Bepridil differentially inhibits two delayed rectifier K+ currents, I Kr and I Ks, in guinea pig ventricular myocytes. Br J Pharmacol 128:1733–1738
Kobayashi S, Reien Y, Ogura T, Saito T, Masuda Y, Nakaya H (2001) Inhibitory effect of bepridil on hKv1.5 channel current: comparison with amiodarone and E-4031. Eur J Pharmacol 430:149–157
Li Y, Sato T, Arita M (1999) Bepridil blunts the shortening of action potential duration caused by metabolic inhibition via blockade of ATP-sensitive K+ channels and Na+-activated K+ channels. J Pharmacol Exp Ther 291:562–568
Hara Y, Nakaya H (1995) SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor operated potassium current in guinea-pig atrial cells. Br J Pharmacol 116:2750–2756
Sato T, Costa AD, Saito T, Ogura T, Ishida H, Garlid KD, Nakaya H (2006) Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels blocks sarcolemmal KATP channels, and confers cardioprotection. J Pharmacol Exp Ther 316:182–188
Sato N, Nishimura M, Kawamura Y, Ward CA, Kikuchi K (1996) Blocks of Na+ channel by bepridil in isolated guinea-pig ventricular myocytes. Eur J Pharmacol 314:373–379
Yatani A, Brown AM, Schwartz A (1986) Bepridil block of cardiac calcium and sodium channels. J Pharmcol Exp Ther 237:9–17
Watanabe Y, Kimura J (2001) Blocking effect of bepridil on Na+/Ca2+ exchange current in guinea pig cardiac ventricular myocytes. Jpn J Pharmacol 85:370–375
Kang L, Zheng MQ, Morishima M, Wang Y, Kaku T, Ono K (2009) Bepridil up-regulates cardiac Na+ channels as a long-term effect by blunting proteasome signals through inhibition of calmodulin activity. Br J Pharmacol 157:404–414
Suzuki S, Kurata Y, Li P, Notsu T, Hasegawa A, Ikeda N, Kato M, Miake J, Sakata S, Shiota G, Yoshida A, Ninomiya H, Higaki K, Yamamoto K, Shirayoshi Y, Hisatome I (2012) Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone. Eur J Pharmacol 696:28–34
Yamashita T, Ogawa S, Sato T, Aizawa Y, Atarashi H, Fujiki A, Inoue H, Ito M, Katoh T, Kobayashi Y, Koretsune Y, Kumagai K, Niwano S, Okazaki O, Okumura K, Saku K, Tanabe T, Origasa H (2009) J-BAF Investigators. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled, double-blind study (J-BAF Study). Circ J 73:1020–1027
Kato R, Singh BN (1986) Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. Am Heart J 111:271–279
Sato D, Niwano S, Imaki R, Masaki Y, Sasaki S, Yuge M, Hirasawa S, Sasaki T, Moriguchi M, Niwano H, Yoshimura H, Izumi T (2006) Bepridil inhibits sub-acute phase of atrial electrical remodeling in canine rapid atrial stimulation model. Circ J 70:206–213
Wang Y, Morishima M, Zheng M, Uchino T, Mannen K, Takahashi A, Nakaya Y, Komuro I, Ono K (2007) Transcription factors Csx/Nkx2.5 and GATA4 distinctly regulate expression of Ca2+ channels in neonatal rat heart. J Mol Cell Cardiol 42:1045–1053
Uchino T, Isomoto S, Noguchi T, Ono K (2013) Window current through the T-type Ca2+ channel triggers the mechanism for cellular apoptosis via mitochondrial pathways. Heart Vessels 28:658–666
Axon Instruments, Inc. (2012) The axon guide: electrophysiology and biophysics laboratory techniques, 3rd edn. Chapter 1: Bioelectricity, pp 17–38
Duff HJ, Offord J, West J, Catterall WA (1992) Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle. Mol Pharmacol 42:570–574
Itoh H, Ishikawa T, Hidaka H (1984) Effects on calmodulin of bepridil, an antianginal agent. J Pharmacol Exp Ther 230:737–741
Zimmer M, Hofmann F (1987) Differentiation of the drug-binding sites of calmodulin. Eur J Biochem 164:411–420
Schaeffer P, Lugnier C, Stoclet JC (1991) Interactions of calmodulin antagonists with calcium antagonists binding sites. Eur J Pharmacol 206:325–332
Kawashiri M, Hayashi K, Konno T, Fujino N, Ino H, Yamagishi M (2014) Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects. Heart Vessels 29:129–141
Yamazaki M, Honjo H, Nakagawa H, Ishiguro YS, Okuno Y, Amino M, Sakuma I, Kamiya K, Kodama I (2007) Mechanisms of destabilization and early termination of spiral wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant. Am J Physiol Heart Circ Physiol 292:H539–H548
Dhamoon AS, Jalife J (2005) The inward rectifier current (I K1) controls cardiac excitability and is involved in arrhythmogenesis. Heart Rhythm 2:316–324
Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U (2005) The G protein-gated potassium current I KACh is constitutively active in patients with chronic atrial fibrillation. Circulation 112:3697–3706
Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Léger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S (2005) Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112:471–481
Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser SH, Ehrlich JR (2009) Changes in microRNA-1 expression and I K1 up-regulation in human atrial fibrillation. Heart Rhythm 6:1802–1809
Luo X, Pan Z, Shan H, Xiao J, Sun X, Wang N, Lin H, Xiao L, Maguy A, Qi XY, Li Y, Gao X, Dong D, Zhang Y, Bai Y, Ai J, Sun L, Lu H, Luo XY, Wang Z, Lu Y, Yang B, Nattel S (2013) MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest 123:1939–1951
Soeki T, Bando S, Uematsu E, Matsuura T, Niki T, Ise T, Kusunose K, Hotchi J, Ueda Y, Tomita N, Yamaguchi K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M (2014) Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart Vessels 229:653–658
Okada A, Kashima Y, Tomita T, Takeuchi T, Aizawa K, Takahashi M, Ikeda U (2014) Characterization of cardiac oxidative stress levels in patients with atrial fibrillation. Heart Vessels. doi:10.1007/S00380-014-0582-8
Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S, Jalife J (2005) Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J 88:3806–3821
Katsouras G, Sakabe M, Comtois P, Maguy A, Burstein B, Guerra PG, Talajic M, Nattel S (2009) Differences in atrial fibrillation properties under vagal nerve stimulation versus atrial tachycardia remodeling. Heart Rhythm 6:1465–1472
Acknowledgments
This study was supported in part by Japanese Ministry of Education, Science, and Culture Grant-in-aid (KAKEN) #25460292 (to K. Ono).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Ma, F., Takanari, H., Masuda, K. et al. Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil. Heart Vessels 31, 1176–1184 (2016). https://doi.org/10.1007/s00380-015-0762-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-015-0762-1